Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry

Completed

Conditions studied: Primary Open-angle Glaucoma

In brief

The purpose of this study is to observe the safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery in subjects with mild to moderate open-angle glaucoma.

Key facts

Study ID

NCT01841437

Run by

Glaukos Corporation

People needed

191

Starts

2013-09-01

Expected to finish

2016-06-21

Last updated by the study team

2017-12-18

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Consecutive subjects in whom implantation of the iStent is attempted

You may not qualify if…

• Please refer to approved indications in Directions for Use

Where it is running

• Study site — Chico, California, United States
• Study site — Huntington Beach, California, United States
• Study site — Napa, California, United States
• Study site — Santa Maria, California, United States
• Study site — Ventura, California, United States
• Study site — Parker, Colorado, United States
• Study site — Portland, Maine, United States
• Study site — Quincy, Massachusetts, United States
• Study site — Bloomington, Minnesota, United States
• Study site — Westwood, New Jersey, United States
• Study site — Durham, North Carolina, United States
• Study site — Fayetteville, North Carolina, United States
• Study site — Southern Pines, North Carolina, United States
• Study site — Brecksville, Ohio, United States
• Study site — Youngstown, Ohio, United States
• Study site — Ladson, South Carolina, United States
• Study site — Sioux Falls, South Dakota, United States
• Study site — Appleton, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.